Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction

Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction

FromJAMA Cardiology Author Interviews


Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction

FromJAMA Cardiology Author Interviews

ratings:
Length:
21 minutes
Released:
Oct 25, 2023
Format:
Podcast episode

Description

Interview with Divaka Perera, MA, MD, author of Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction: A Prespecified Secondary Analysis of the REVIVED-BCIS2 Trial, and Julio A. Panza, MD, author of Assessment of Myocardial Viability in Ischemic Cardiomyopathy—Scarred by the Data but Still Alive. Hosted by James E. Udelson, MD. Related Content: Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction Assessment of Myocardial Viability in Ischemic Cardiomyopathy—Scarred by the Data but Still Alive
Released:
Oct 25, 2023
Format:
Podcast episode

Titles in the series (100)

Interviews with authors of articles from JAMA Cardiology. JAMA Cardiology publishes exceptional original research, state-of-the-art reviews, and informative opinions that advance the science and practice of cardiology, enhance cardiovascular health, and inform health care policy. JAMA Cardiology is the definitive journal for clinical investigators, clinicians, and trainees in cardiovascular medicine worldwide. JAMA Cardiology focuses on all aspects of cardiovascular medicine, including epidemiology and prevention, diagnostic testing, interventional and pharmacologic therapeutics, translational research, health care policy and outcomes, and global health.